SNT 2.44% 4.0¢ syntara limited

cystic fibrosis trial reaches target recruitment, page-13

  1. 1,300 Posts.
    lightbulb Created with Sketch. 69
    re: pxs Not sure if we'll hear anything this week - but we are waiting on the following imminent announcements:

    * EU Marketing application (soon)
    * EU Distribution partner (one would assume this would come after the Marketing application)
    * Cystic Fibrosis results (1-4 weeks)
    * Possible Orphan Drug status for Brochitiol/CF & FDA fast-track
    * Start of Phase 3 Aridol Trial in US
    * TGA approval (probably still a couple of months away)
    * Start US Phase 3 trial for Bronchiectasis/Bronchitol (3Q 05)
    * Final Phase 2 Trial Results Cystic Fibrosis for Bronchitol (3Q 05)
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.